OverviewChartNewsTraderScreen

BVT Knock-Out GNMSF/  DE000VE93FP5  /

EUWAX
29/05/2024  08:45:15 Chg.-0.39 Bid22:00:44 Ask22:00:44 Underlying Strike price Expiration date Option type
8.47EUR -4.40% -
Bid Size: -		 -
Ask Size: -		 Genmab A/S 1,272.11 DKK 31/12/2078 Call
GlobeNewswire 29/05 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 21/05 Genmab Completes Acquisition of ProfoundBio
GlobeNewswire 21/05 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 17/05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 14/05 Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization...
GlobeNewswire 14/05 Immatics Announces First Quarter 2024 Financial Results and Business Update
GlobeNewswire 06/05 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 02/05 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 30/04 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...
GlobeNewswire 22/04 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 07/04 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 03/04 Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
GlobeNewswire 20/03 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 20/03 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 11/03 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 07/03 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 06/03 BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...
GlobeNewswire 04/03 Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of ...
GlobeNewswire 14/02 Genmab Announces Initiation of Share Buy-Back Program
GlobeNewswire 14/02 Genmab Publishes 2023 Annual Report
GlobeNewswire 08/02 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 08/02 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 31/01 BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjuga...
GlobeNewswire 22/01 BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/...
GlobeNewswire 09/01 BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference